The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 4, 2009, Pages 739-744

  Calabria, Christopher W ^a   Coop, Christopher A ^a   Tankersley, Michael S ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

large local reaction; Local reaction; safety; subcutaneous immunotherapy; systemic reaction

Indexed keywords

ALLERGEN; FEXOFENADINE; HYMENOPTERA EXTRACT; IMMUNOLOGIC AGENT; IMPORTED FIRE ANT; LORATADINE; MONTELUKAST; PLACEBO; TERFENADINE; UNCLASSIFIED DRUG;

ARTICLE; HAND PALM; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; DESENSITIZATION; DOSE RESPONSE; HYPERSENSITIVITY; IMMUNOLOGY; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; INJECTIONS, SUBCUTANEOUS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 70449715260     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.07.048     Document Type: Article

References (20)

1. Prigal S.A. Ten-year study of repository injections of allergens: local reactions and their management. Ann Allergy 30 (1972) 529-535
2. Ramirez D., Londono S., and Evans R. Adverse reactions to venom immunotherapy. Ann Allergy Asthma Immunol 47 (1981) 435-439
3. Nelson B.L., Dupont L.A., and Reid M.J. Prospective survey of local and systemic reactions to immunotherapy with pollen extracts. Ann Allergy 56 (1986) 331-334
4. Calabria C., Coop C., and Tankersley M. The GILL study: glycerin induced local reactions in immunotherapy. J Allergy Clin Immunol 121 (2008) 222-226
5. Tankersley M.S., Butler K.K., Butler W.K., and Goetz D.W. Local reactions during allergen immunotherapy do not require dose adjustment. J Allergy Clin Immunol 106 (2000) 840-843
6. Coop C.A., and Tankersley M.S. Dose adjustments among allergists for local reactions from immunotherapy. Ann Allergy Asthma Immunol 99 (2007) 77-81
7. Kelso J.M. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction. Ann Allergy Asthma Immunol 92 (2004) 225-227
8. Nielsen L., Johnsen C., Mosbech H., Poulsen L., and Malling H.J. Antihistamine pre-medication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 97 (1996) 1207-1213
9. Portnoy J., Bagstad K., Kanarek H., Pacheco F., Hall B., and Barnes C. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Ann Allergy Asthma Immunol 73 (1994) 409-418
10. More D., and Hagan L. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol 88 (2002) 391-394
11. Allergen immunotherapy: a practice parameter second update. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol 120 (2007) S25-S85
12. Kain Z.N., and MacLaren J. P less than .05: what does it really mean?. Pediatrics 119 (2007) 608-610
13. Roy S., Sigmon J., Olivier J., Moffitt J., Brown D., and Marshall D. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 99 (2007) 82-86
14. Coop C.A., and Tankersley M.S. Patient perceptions regarding local reactions from allergen immunotherapy injections. Ann Allergy Asthma Immunol 101 (2008) 96-100
15. Reimers A., Hari Y., and Muller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 55 (2000) 484-488
16. Brockow K., Kiehn M., Riethmuller C., Vieluf D., Berger J., and Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100 (1997) 458-463
17. Berchtold E., Maibach R., and Muller U. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 22 (1992) 59-65
18. Ohashi Y., Nakai Y., and Murata K. Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. Ann Allergy Asthma Immunol 96 (2006) 600-605
19. Wohrl S., Gamper S., Hemmer W., Heinze G., Stingl G., and Kinaciyan T. Premedication with montelukast reduces local reactions of allergen immunotherapy. Int Arch Allergy Immunol 144 (2007) 137-142
20. Heijaoui A., Ferrando R., Dhivert H., Michel F.B., and Bousquet J. Systemic reactions occurring during immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 89 (1992) 925-933